MapLight Therapeutics, Inc. MPLT Balance Sheet Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $46.73M+22.2% | $38.25M— | ||
| $258.37M+266% | $70.54M— | ||
| $324.67M+183% | $114.6M— | ||
| $1.1M-9.3% | $1.21M— | ||
| $479.51M+250% | $136.92M— | ||
| $3.29M+72.0% | $1.91M— | ||
| $16.23M+1.9% | $15.92M— | ||
| $21.14M-2.7% | $21.72M— | ||
| $5K— | $0— | ||
| -$360.52M-80.8% | -$199.37M— | ||
| $458.37M+337% | -$193.63M-64.7% | ||
| $479.51M+250% | $136.92M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MapLight Therapeutics, Inc. 's total assets?
- MapLight Therapeutics, Inc. (MPLT) holds $418.8M in total assets.
- How much debt does MapLight Therapeutics, Inc. have?
- MapLight Therapeutics, Inc. carries $5.6M in total debt against $399.8M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does MapLight Therapeutics, Inc. have?
- MapLight Therapeutics, Inc. holds $55.7M in cash and equivalents.
- Can MapLight Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 22.91 — current assets exceed current liabilities.
- Where does MapLight Therapeutics, Inc. 's balance sheet data come from?
- Every line is extracted from MapLight Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.